Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (431-440 of 675) with videos related to

Pageof 68
Sort By:
Angiology|August 4, 2009
Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemiaKali G Makedou, Dimitri P Mikhailidis, Areti Makedou, et al.
Andrology|May 17, 2021
The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic reviewPanagiotis Anagnostis, Dimitrios Papanikolaou, Pinelopi G Ioannidou, et al.
Current Vascular Pharmacology|May 9, 2014
Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary reportKonstantinos Kargiotis, Niki Katsiki, Vasilios G Athyros, et al.
Current Vascular Pharmacology|April 14, 2006
The management of phosphodiesterase-5 (PDE5) inhibitor failureDavid H W Lau, Sashi Kommu, Faiz H Mumtaz, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2022
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current EvidenceEmir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, et al.
Current Medical Research and Opinion|May 24, 2007
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaMihalis Kalogirou, Vasilis Tsimihodimos, Irene Gazi, et al.
Platelets|November 26, 2005
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?Evangelos N Liberopoulos, Moses S Elisaf, Alexandros D Tselepis, et al.
Annals of Medicine|August 14, 2018
Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Dimitri P Mikhailidis, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemiaEmmanuel S Ganotakis, Irene F Gazi, John A Papadakis, et al.
Atherosclerosis|July 18, 2018
Dietary inflammatory index and cardiometabolic risk in US adultsMohsen Mazidi, Nitin Shivappa, Michael D Wirth, et al.
Pageof 68

Showing results (431-440 of 675) with videos related to

Sort By:
Pageof 68
Angiology|August 4, 2009
Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemiaKali G Makedou, Dimitri P Mikhailidis, Areti Makedou, et al.
Andrology|May 17, 2021
The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic reviewPanagiotis Anagnostis, Dimitrios Papanikolaou, Pinelopi G Ioannidou, et al.
Current Vascular Pharmacology|May 9, 2014
Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary reportKonstantinos Kargiotis, Niki Katsiki, Vasilios G Athyros, et al.
Current Vascular Pharmacology|April 14, 2006
The management of phosphodiesterase-5 (PDE5) inhibitor failureDavid H W Lau, Sashi Kommu, Faiz H Mumtaz, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2022
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current EvidenceEmir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, et al.
Current Medical Research and Opinion|May 24, 2007
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaMihalis Kalogirou, Vasilis Tsimihodimos, Irene Gazi, et al.
Platelets|November 26, 2005
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?Evangelos N Liberopoulos, Moses S Elisaf, Alexandros D Tselepis, et al.
Annals of Medicine|August 14, 2018
Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Dimitri P Mikhailidis, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemiaEmmanuel S Ganotakis, Irene F Gazi, John A Papadakis, et al.
Atherosclerosis|July 18, 2018
Dietary inflammatory index and cardiometabolic risk in US adultsMohsen Mazidi, Nitin Shivappa, Michael D Wirth, et al.
Pageof 68